M&A Deal Summary

CooperSurgical Acquires Teva Pharmaceutical Industries - PARAGARD

On September 11, 2017, CooperSurgical acquired medical products company Teva Pharmaceutical Industries - PARAGARD from Teva Pharmaceutical Industries for 1.1B USD

Acquisition Highlights
  • This is CooperSurgical’s 8th transaction in the Medical Products sector.
  • This is CooperSurgical’s largest (disclosed) transaction.
  • This is CooperSurgical’s 8th transaction in the United States.
  • This is CooperSurgical’s 1st transaction in New York.

M&A Deal Summary
Date 2017-09-11
Target Teva Pharmaceutical Industries - PARAGARD
Sector Medical Products
Buyer(s) CooperSurgical
Sellers(s) Teva Pharmaceutical Industries
Deal Type Divestiture
Deal Value 1.1B USD

Target

Teva Pharmaceutical Industries - PARAGARD

Buffalo, New York, United States
PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CooperSurgical

Trumbull, Connecticut, United States
Category Company
Founded 1990
Sector Medical Products
DESCRIPTION

CooperSurgical, Inc. is a developer of surgical medical products.

DEAL STATS #
Overall 12 of 13
Sector (Medical Products) 8 of 9
Type (Divestiture) 4 of 4
State (New York) 1 of 1
Country (United States) 8 of 9
Year (2017) 1 of 1
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-06 Smiths Group - Wallace Product Line

London, United Kingdom

Smiths Group plc - Wallace Product Line includes the in-vitro fertilization (IVF) segment.

Buy $168M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-02 AEGEA Medical

Menlo Park, California, United States

AEGEA Medical provides an application for its water vapor ablation technology to deliver therapies that provide high-quality patient outcomes to a wider range of women. AEGEA’s FDA approved Mara Water Vapor Ablation System enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. Founded in 2008, AEGEA Medical is located in Menlo Park, California.

Buy -

Seller(S) 1

SELLER

Teva Pharmaceutical Industries

Tel Aviv, Israel
Category Company
Founded 1901
Sector Life Science
Employees35,001
Revenue 15.8B USD (2023)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.

DEAL STATS #
Overall 5 of 9
Sector (Medical Products) 1 of 1
Type (Divestiture) 5 of 8
State (New York) 1 of 1
Country (United States) 2 of 3
Year (2017) 1 of 2
Size (of disclosed) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-02 Anda

Parsippany, New Jersey, United States

Anda, Inc. is a distributor of generic pharmaceuticals.

Buy $500M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-18 Plan B One-Step

Petach Tikva, Israel

Plan B One-Step comprises of value brands of emergency contraception, Take Action, Aftera, and Next Choice One Dose.

Sell $675M
Mergr

Product

Company

Legal